| Literature DB >> 11152935 |
G Yu1, L LeBrun, N S Gunay, D Hoppensteadt, J M Walenga, J Fareed, R J Linhardt.
Abstract
A synthetic pentasaccharide, containing an intact antithrombin III (ATIII) binding site that is in clinical studies a specific antifactor Xa agent, serves as a substrate for a heparin lyase (heparinase I, EC 4.2.2.7) from Flavobacterium heparinum. Heparinase I, currently being assessed as a heparin reversal agent, also reverses the antifactor Xa activity of this synthetic pentasaccharide by breaking it down to inactive disaccharide and trisaccharide products.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11152935 DOI: 10.1016/s0049-3848(00)00368-6
Source DB: PubMed Journal: Thromb Res ISSN: 0049-3848 Impact factor: 3.944